Health-related quality of life burden associated with treatment-resistant depression in UK patients: Quantitative results from a mixed-methods non-interventional study

The reliability and validity of PHQ-9 in patients with major depressive disorder in psychiatric hospital

(2020) Yue Sun et al.   BMC Psychiatry

Real-world evidence from a European cohort study of patients with treatment resistant depression: Baseline patient characteristics

(2020) K. Heerlein et al.   JOURNAL OF AFFECTIVE DISORDERS

Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study

(2019) Vanina Popova et al.   AMERICAN JOURNAL OF PSYCHIATRY

Comparison of the Usefulness of the PHQ-8 and PHQ-9 for Screening for Major Depressive Disorder: Analysis of Psychiatric Outpatient Data

(2019) Cheolmin Shin et al.   Psychiatry Investigation

The humanistic and economic burden of treatment-resistant depression in Europe: a cross-sectional study

(2019) Dena H. Jaffe et al.   BMC Psychiatry

The burden of treatment-resistant depression: a systematic review of the economic and quality of life literature

(2018) Karissa Johnston et al.   JOURNAL OF AFFECTIVE DISORDERS

Mortality in treatment-resistant unipolar depression: A register-based cohort study in Sweden

(2018) Johan Reutfors et al.   JOURNAL OF AFFECTIVE DISORDERS

Quality of life across domains among individuals with treatment-resistant depression

(2018) Heidemarie Lex et al.   JOURNAL OF AFFECTIVE DISORDERS

Work Productivity Loss With Depression, Diagnosed and Undiagnosed, Among Workers in an Internet-Based Survey Conducted in Japan

(2015) Yuko Asami et al.   JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE

Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines

(2015) Anthony Cleare et al.   JOURNAL OF PSYCHOPHARMACOLOGY

A Review of the Clinical, Economic, and Societal Burden of Treatment-Resistant Depression: 1996–2013

(2014) David A. Mrazek et al.   PSYCHIATRIC SERVICES

Equations for converting scores between depression scales (MÅDRS, SRS, PHQ-9 and BDI-II): good statistical, but weak idiographic, validity

(2013) Chris J. Hawley et al.   HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

Treatment-resistant depression: Definitions, review of the evidence, and algorithmic approach

(2013) Roger S. McIntyre et al.   JOURNAL OF AFFECTIVE DISORDERS

Patient-reported Depression Severity Measured by the PHQ-9 and Impact on Work Productivity

(2013) Gagan Jain et al.   JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE

Characterization of Treatment Resistant Depression Episodes in a Cohort of Patients from a US Commercial Claims Database

(2013) Nicole Kubitz et al.   PLoS One

Interim Scoring for the EQ-5D-5L: Mapping the EQ-5D-5L to EQ-5D-3L Value Sets

(2012) Ben van Hout et al.   VALUE IN HEALTH

Validation of PHQ-2 and PHQ-9 to Screen for Major Depression in the Primary Care Population

(2010) B. Arroll et al.   ANNALS OF FAMILY MEDICINE

Treatment-Resistant Depression: Critique of Current Approaches

(2009) Chanaka Wijeratne et al.   AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY

Employer burden of mild, moderate, and severe major depressive disorder: mental health services utilization and costs, and work performance

(2009) Howard G. Birnbaum et al.   DEPRESSION AND ANXIETY

Psychometric comparison of PHQ-9 and HADS for measuring depression severity in primary care

(2007) Isobel M Cameron et al.   BRITISH JOURNAL OF GENERAL PRACTICE